Cargando…
Asymmetric Organocatalysis: A Survival Guide to Medicinal Chemists †
Majority of drugs act by interacting with chiral counterparts, e.g., proteins, and we are, unfortunately, well-aware of how chirality can negatively impact the outcome of a therapeutic regime. The number of chiral, non-racemic drugs on the market is increasing, and it is becoming ever more important...
Autores principales: | Reyes, Efraim, Prieto, Liher, Milelli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822454/ https://www.ncbi.nlm.nih.gov/pubmed/36615465 http://dx.doi.org/10.3390/molecules28010271 |
Ejemplares similares
-
Asymmetric Organocatalysis at the Service of Medicinal Chemistry
por: Ricci, Alfredo
Publicado: (2014) -
The Emergence of Quinone Methides in Asymmetric Organocatalysis
por: Caruana, Lorenzo, et al.
Publicado: (2015) -
New advances in asymmetric organocatalysis
por: Šebesta, Radovan
Publicado: (2022) -
Cross-trienamines in Asymmetric
Organocatalysis
por: Halskov, Kim Søholm, et al.
Publicado: (2012) -
Electrostatic
Interactions in Asymmetric Organocatalysis
por: Maji, Rajat, et al.
Publicado: (2023)